New Visiongain report says that the Global Electrosurgical Energy Devices Market Set To Grow To $4.9bn By 2023

30 July 2018
Pharma

Visiongain’ has launched a new pharma report Electrosurgical Energy Devices Market Report : Electrosurgical Generators, Instruments and Accessories, Argon and Smoke Management Systems, Bipolar Instruments, Monopolar Instruments, Patient Return Electrodes, Dispersive Electrodes, Cords, Cables and Adapters, General Surgery, Gynaecologic, Urologic, Orthopaedic, Cardiovascular, Cosmetic, Neurosurgery

The electrosurgical energy devices market is driven by factors such as increasing geriatric population, increasing demand for minimally invasive surgeries, and the launch of technologically advanced electrosurgical energy devices. However, pitfalls such as stringent government regulations are restraining the market for electrosurgical energy devices.
By product type, electrosurgical instruments and accessories dominated the market in 2017 owing to the high use of instruments and accessories in different surgical procedures such as cosmetic surgery, neurosurgery, cardiovascular surgery, urologic surgery, general surgery and others.

The lead analyst of the report commented “The growth of the electrosurgical device market is estimated to be catalysed by opportunities in untapped, emerging markets with high potential due to improving healthcare infrastructure, unmet healthcare needs, rise in chronic diseases and increased demands for minimally invasive surgeries.

The healthcare industry in emerging economies is developing at a significant rate due to augmentation in demand for better healthcare services, significant investments to improve healthcare infrastructure and growth of medical tourism industry in emerging countries.”

Leading companies featured in the report include B. Braun Melsungen AG, Bovie Medical Corporation, Conmed, ERBE Elektromedizin GmbH , Johnson & Johnson, KLS Martin Group, Medtronic, Megadyne Medical Products, Inc., Olympus Corporation, Utah Medical Products, Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

Read

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever